Citadel Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Buy
126,403
+106,858
+547% +$1.41M ﹤0.01% 6791
2025
Q4
$296K Buy
+19,545
New +$298K ﹤0.01% 10185
2025
Q3
Sell
-12,043
Closed -$158K 13717
2025
Q2
$134K Sell
12,043
-93,452
-89% -$1.16M ﹤0.01% 11060
2025
Q1
$1.72M Sell
105,495
-44,948
-30% -$789K ﹤0.01% 5828
2024
Q4
$2.63M Sell
150,443
-137,213
-48% -$2.39M ﹤0.01% 5072
2024
Q3
$4.49M Sell
287,656
-44,222
-13% -$708K ﹤0.01% 4100
2024
Q2
$4.4M Buy
331,878
+120,986
+57% +$1.66M ﹤0.01% 3955
2024
Q1
$3.06M Sell
210,892
-60,026
-22% -$830K ﹤0.01% 4753
2023
Q4
$3.65M Buy
270,918
+31,909
+13% +$375K ﹤0.01% 4304
2023
Q3
$3.07M Buy
239,009
+24,566
+11% +$442K ﹤0.01% 4436
2023
Q2
$3.87M Buy
214,443
+162,964
+317% +$3.04M ﹤0.01% 4036
2023
Q1
$862K Sell
51,479
-84,941
-62% -$1.66M ﹤0.01% 7116
2022
Q4
$2.8M Sell
136,420
-60,140
-31% -$1.06M ﹤0.01% 4861
2022
Q3
$3.76M Buy
196,560
+53,530
+37% +$1.2M ﹤0.01% 4364
2022
Q2
$3.37M Sell
143,030
-12,795
-8% -$366K ﹤0.01% 4555
2022
Q1
$5.1M Buy
155,825
+139,934
+881% +$4.5M ﹤0.01% 4134
2021
Q4
$494K Sell
15,891
-42,624
-73% -$1.42M ﹤0.01% 9729
2021
Q3
$2.23M Buy
58,515
+28,052
+92% +$1.12M ﹤0.01% 6076
2021
Q2
$1.22M Sell
30,463
-11,016
-27% -$465K ﹤0.01% 7820
2021
Q1
$1.8M Sell
41,479
-14,536
-26% -$641K ﹤0.01% 6653
2020
Q4
$2.41M Buy
56,015
+13,523
+32% +$494K ﹤0.01% 4972
2020
Q3
$1.32M Sell
42,492
-33,326
-44% -$1.03M ﹤0.01% 5516
2020
Q2
$2.43M Sell
75,818
-67,159
-47% -$2.23M ﹤0.01% 4230
2020
Q1
$4M Buy
142,977
+20,430
+17% +$790K ﹤0.01% 3027
2019
Q4
$5.66M Buy
122,547
+65,287
+114% +$3.07M ﹤0.01% 2928
2019
Q3
$3.04M Sell
57,260
-19,207
-25% -$991K ﹤0.01% 3822
2019
Q2
$4.04M Buy
76,467
+5,011
+7% +$267K ﹤0.01% 3413
2019
Q1
$4.03M Sell
71,456
-68,631
-49% -$3.85M ﹤0.01% 3297
2018
Q4
$7.35M Buy
140,087
+43,542
+45% +$2.48M ﹤0.01% 2271
2018
Q3
$5.58M Buy
96,545
+7,152
+8% +$401K ﹤0.01% 2858
2018
Q2
$5.08M Buy
89,393
+63,273
+242% +$3.6M ﹤0.01% 2752
2018
Q1
$1.53M Buy
26,120
+776
+3% +$43.5K ﹤0.01% 4136
2017
Q4
$1.39M Buy
25,344
+14,031
+124% +$728K ﹤0.01% 4151
2017
Q3
$535K Buy
11,313
+5,138
+83% +$242K ﹤0.01% 5223
2017
Q2
$287K Sell
6,175
-42,202
-87% -$1.75M ﹤0.01% 5974
2017
Q1
$1.85M Buy
48,377
+36,463
+306% +$1.35M ﹤0.01% 3162
2016
Q4
$431K Buy
+11,914
New +$452K ﹤0.01% 5145
2016
Q3
Sell
-5,226
Closed -$222K 7595
2016
Q2
$222K Buy
+5,226
New +$227K ﹤0.01% 5673
2015
Q4
Sell
-1,584
Closed -$53K 9042
2015
Q3
$53K Sell
1,584
-60,026
-97% -$2.14M ﹤0.01% 7539
2015
Q2
$2.04M Buy
61,610
+44,809
+267% +$1.54M ﹤0.01% 3040
2015
Q1
$603K Sell
16,801
-19,825
-54% -$623K ﹤0.01% 4635
2014
Q4
$1.1M Buy
+36,626
New +$1.07M ﹤0.01% 3652
2014
Q3
Sell
-2,257
Closed -$74.9K 8317
2014
Q2
$82K Sell
2,257
-17,122
-88% -$553K ﹤0.01% 6389
2014
Q1
$585K Sell
19,379
-74,219
-79% -$1.71M ﹤0.01% 4123
2013
Q4
$2.13M Buy
93,598
+31,674
+51% +$662K ﹤0.01% 2488
2013
Q3
$1.29M Buy
61,924
+37,603
+155% +$913K ﹤0.01% 2836
2013
Q2
$654K Buy
+24,321
New +$729K ﹤0.01% 3584

Other funds holding OFIX

Citadel Advisors's OFIX Position: Q1 2026 in Review

Citadel Advisors increased its Orthofix Medical (OFIX) stake by 547% in Q1 2026, buying an estimated $1.41M and bringing the position to 126,403 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #6791.

Citadel Advisors first reported a position in OFIX in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.35M in Q4 2018. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Citadel Advisors held 126,403 shares of Orthofix Medical worth $1.45M as of Q1 2026.
  • Citadel Advisors bought 106,858 Orthofix Medical shares in Q1 2026, an estimated $1.41M.
  • Orthofix Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6791 holding.
  • Citadel Advisors first reported a position in Orthofix Medical in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Orthofix Medical position peaked at $7.35M in Q4 2018.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.